Table 1.

Patients with clinically ambiguous dementia diagnoses (DLB versus AD) at the moment of MIBG cardiac scintigraphy

Subject number	Gender	Age	Follow-up (months)	H/M ratio	Possibly interfering medication	Cardiovascular comorbidity, LVEF (if available)	Follow-up diagnosis	Core features of DLB	Suggestive features of DLB
1	M	73	7	1.71	–	Hyperlipidemia, AHT, IHD, LVEF 59%	No dementia
2	F	81	7	1.41	–	AHT, LVEF 60%	DLB	F/H/P
3	M	79	10	1.10	–		DLB	F/H/P
4	M	73	6	1.30	–	AHT, IHD, heart failure	DLB	H/P	Positive DAT scan
5	M	78	1	1.76	–	–	Definite AD	H/P
6	M	87	11	1.62	–	–	DLB	F/H/P
7	M	77	8	1.47	Trazodone	LVEF 63%	AD with CVD	H
8	M	78	19	1.05	–		DLB	F
9	M	76	21	1.10	–	IHD, heart failure	DLB	H/P
10	F	83	17	1.24	–	–	DLB	P	Severe neuroleptic sensitivity
11	F	75	17	1.38	–	AHT, AF, myocardial hypertrophy, LVEF 65%	DLB	F
12	M	71	15	1.34	Trazodone	AHT, LVEF 70%	DLB	F/H/P
13	M	72	8	1.23	–	AHT, AF	DLB	P
14	M	72	44	2.20	–	–	AD	F/H/P	Severe neuroleptic sensitivity
15	F	81	6	0.97	–	–	DLB	P	Positive DAT scan
16	F	79	18	1.44	–	–	AD + PD	P
17	M	84	31	1.11	Trazodone	Hyperlipidemia, AHT	DLB	F	Positive DAT scan and REM sleep behavior disorder
18	M	75	6	1.61	Trazodone	–	DLB	H/P	Severe neuroleptic sensitivity
19	M	74	13	0.99	Trazodone	Hyperlipidemia, IHD, AF	DLB	F/H/P
20	M	75	57	1.07		–	PDD	F/H/P	REM sleep behavior disorder

Abbreviations: AF = atrial fibrillation; AHT = arterial hypertension; DLB = dementia with Lewy bodies; H = visual hallucinations; IHD = ischemic heart disease; F = fluctuating cognition; LVEF = left ventricular ejection fraction; P = Parkinsonism; DAT = dopamine transporter imaging; CVD = cerebrovascular disease; PD = Parkinson’s disease.